Nasu–Hakola disease also known as Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL)
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0343274
Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL), also called Nasu–Hakola disease, is a very rare genetic disorder that affects both the brain and the bones. People with this condition often develop bone cysts, memory loss, personality changes, and eventually severe dementia. Because the disease is so uncommon, there are no effective treatments, and scientists still do not fully understand how it develops. This study used computer-based methods to explore the biology behind PLOSL and to search for possible drugs that might help in the future. The researchers analysed gene expression data to find which genes behave differently in people with PLOSL compared to healthy individuals. They then used a systems biology approach to map how these genes and their proteins interact inside the body. This helped them identify “hub genes,” which act like central control points in important biological processes. Many of these genes were linked to inflammation, immune system activity, and cell signalling pathways, changes that may explain the brain and bone symptoms seen in patients. The team then used molecular docking, a computer technique that predicts how well drug molecules attach to specific proteins. Several promising drug candidates were identified. Although these results are early and based only on computer models, they provide valuable clues for future laboratory research and potential treatment development.